BrUOG 244: PPX and Concurrent Radiation for Newly
Diagnosed Glioblastoma Without MGMT Methylation: A
Randomized Phase II Study
PI: Howard Safran, MD
Sites: Rhode Island Hospital
RTOG 0913: Phase I/II Trial of Concurrent RAD001
(Everolimus) With Temozolomide/Radiation Followed by
Adjuvant RAD001/Temozolomide in Newly Diagnosed
Glioblastoma
PI: Suriya Jeyapalan, MD
Sites: Rhode Island Hospital
RTOG 0929: A Randomized Phase I/II Study of ABT-888 in
Combination With Temozolomide in Recurrent (Temozolomide
Resistant) Glioblastoma
PI: Heinrich Elinzano, MD
Sites: Rhode Island Hospital
LS-P-DCVax: A Phase II Clinical Trial Evaluating
DCVax®-Brain, Autologous Dendritic Cells Pulsed with
Tumor Lysate Antigen for the Treatment of Glioblastoma
Multiforme
PI: Heinrich Elinzano, MD
Site: Rhode Island Hospital
LS-P-Celldex: A Phase II Study of Rindopepimut/GM-CSF in
Patients with Relapsed EGFRvIII-Positive Glioblastoma
PI: Heinrich Elinzano, MD
Site: Rhode Island Hospital
167 Point Street
Providence, RI 02903
401-444-3500 | Email Us
Terms of Use |
Privacy
Corporate Compliance
©2013 Lifespan |
Site
Map
Learn about patient safety, quality of care and patient satisfaction at Lifespan.